| Target Price | €127.50 |
| Price | €113.30 |
| Potential |
12.53%
register free of charge
|
| Number of Estimates | 15 |
|
15 Analysts have issued a price target bioMerieux SA 2026 .
The average bioMerieux SA target price is €127.50.
This is
12.53%
register free of charge
€147.00
29.74%
register free of charge
€90.90
19.77%
register free of charge
|
|
| A rating was issued by 18 analysts: 10 Analysts recommend bioMerieux SA to buy, 7 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the bioMerieux SA stock has an average upside potential 2026 of
12.53%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion € | 3.98 | 4.23 |
| 8.31% | 6.36% | |
| EBITDA Margin | 16.25% | 24.33% |
| 2.03% | 49.71% | |
| Net Margin | 10.86% | 12.87% |
| 11.59% | 18.51% |
15 Analysts have issued a sales forecast bioMerieux SA 2025 . The average bioMerieux SA sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an bioMerieux SA EBITDA forecast 2025. The average bioMerieux SA EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
16 bioMerieux SA Analysts have issued a net profit forecast 2025. The average bioMerieux SA net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share € | 3.64 | 4.61 |
| 20.93% | 26.65% | |
| P/E | 24.56 | |
| EV/Sales | 3.20 |
16 Analysts have issued a bioMerieux SA forecast for earnings per share. The average bioMerieux SA EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ODDO BHF |
Locked
➜
Locked
|
Locked | Sep 05 2025 |
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Sep 04 2025 |
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Jul 18 2025 |
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Jul 17 2025 |
| ESN/CIC MARKET SOLUTIONS |
Locked
➜
Locked
|
Locked | May 28 2025 |
| ESN/CIC MARKET SOLUTIONS |
Locked
➜
Locked
|
Locked | May 27 2025 |
| HSBC |
Locked
➜
Locked
|
Locked | May 26 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Sep 05 2025 |
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Sep 04 2025 |
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Jul 18 2025 |
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Jul 17 2025 |
|
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
|
May 28 2025 |
|
Locked
ESN/CIC MARKET SOLUTIONS:
Locked
➜
Locked
|
May 27 2025 |
|
Locked
HSBC:
Locked
➜
Locked
|
May 26 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


